Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 20/20 | 1.00 |
| ▸ | ITGA2B | P08514 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7449964 | 0.81 | ITGB3 (0.68) | ITGB3ITGA2B | |
| SCHEMBL7442644 | 0.81 | ITGB3 (0.68) | ITGB3ITGA2B | |
| SCHEMBL7447180 | 0.81 | ITGB3 (0.68) | ITGB3ITGA2B | |
| Hydrochloric Acid SCHEMBL7450135 | 0.81 | ITGB3 (0.68) | ITGB3ITGA2B | |
| Trifluoroacetic Acid SCHEMBL7793879 | 0.78 | ITGB3 (0.64) | ITGB3ITGA2B | |
| SCHEMBL7090791 | 0.77 | ITGB3 (0.89) | ITGB3ITGA2B | |
| SCHEMBL21706030 | 0.75 | ITGB3 (0.75) | ITGB3ITGA2B | |
| SCHEMBL7213411 | 0.75 | ITGB3 (0.59) | ITGB3ITGA2B | |
| SCHEMBL7213400 | 0.74 | ITGB3 (1.00) | ITGB3ITGA2B | |
| SCHEMBL9093406 | 0.73 | ITGB3 (0.57) | ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6794412-B1 | Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-09-21 | — | — | US | disclosed |
| US-6794412-B1 | Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-09-21 | — | — | US | disclosed |